Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice - Test2 - elhamkhani - TriplyDB

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

http://www.wikidata.org/entity/Q30357432

about

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells The influenza virus enigma Current and future antiviral therapy of severe seasonal and avian influenza Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection The structural basis for serotype-specific neutralization of dengue virus by a human antibody Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection What is the optimal therapy for patients with H5N1 influenza?Prevention and treatment of influenza with hyperimmune bovine colostrum antibody Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza Avian influenza virus (H5N1): a threat to human health.Influenza A/H5N1 infection: other treatment options and issues.An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.Avian influenza: the threat of the 21st century.Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.A novel monoclonal antibody effective against lethal challenge with swine-lineage and 2009 pandemic H1N1 influenza viruses in mice.Targets for the induction of protective immunity against influenza a viruses.A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.Passive immune neutralization strategies for prevention and control of influenza A infections.Dengue virus compartmentalization during antibody-enhanced infection.Dengue virus activates cGAS through the release of mitochondrial DNA Identification of a human monoclonal Fab with neutralizing activity against H3N2 influenza A strain from a newly constructed human Fab library.Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1.Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China.Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.Hypoxia enhances antibody-dependent dengue virus infection An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein.Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses Dengue virus neutralization in cells expressing Fc gamma receptors Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.H5N1 influenza virus pathogenesis in genetically diverse mice is mediated at the level of viral load.

P2860

Q21562507-74388176-1DA2-434B-8843-C18B3802603B Q24616614-AA153CDA-91A7-4727-8EE4-7AEEE7F6B464 Q24656164-35910618-C70F-405B-AEF0-8875C4F2C554 Q27324824-71919081-A238-40ED-9675-D565570A54DF Q27681306-2D300257-9957-46F8-8C92-037D626138C0 Q28308105-212342AA-A2B0-4710-A5E8-628DF1179A11 Q28475630-8FEE2481-EC28-4727-8F84-5B6BF212BB1E Q28748705-528C250A-0D7D-4514-B344-05F038B1086C Q28757651-CC92FB3D-7E8C-4C80-85A7-B93152DAF366 Q30361041-2A88637E-CCC2-4FA4-AEB6-F019B133B0C8 Q30368453-D84C52AC-E991-41F5-AC82-2D413984CE0A Q30371674-88FE709D-813C-44B8-8277-C0EE5F10D365 Q30372987-A73100D6-E7A5-41E2-8151-702A7053699C Q30376814-AA8E0C81-AF13-4A55-944D-F491CB02FAAA Q30377663-EB370B3B-F7BB-4400-89EC-3C1967A780D7 Q30378353-9F8E2D18-C2D8-4786-A423-E34FAEB5B109 Q30378572-ECDE0683-828E-4A63-AB1C-82EA3F4157A4 Q30388253-E08BC96B-5A79-440B-B117-81712E6397D9 Q30391974-78DFE37B-E3E7-49EE-BB48-E2185921284A Q30398715-9194B1CB-24D8-4ADD-ACB0-14875D16AFF7 Q30405066-50B21AE4-8B21-4E68-8485-19F35869A4FC Q30408100-84805F16-97CD-436C-813E-BBBBFC62BAE7 Q30411637-60E95D83-6772-4604-AAAF-21C6587E67FF Q30413158-A8DE3BEC-C63F-4FCD-9FAE-50A28CCB90AF Q30834861-2318A733-5DD1-4DD0-A5A6-5833999C974B Q30855840-95E438BD-52CE-4C5B-A8AA-4BBF2EF62730 Q33327547-BCA254DA-F4CD-4031-8622-ACC7C7ECA3DF Q33328393-1ED41E24-46B2-4C64-92DA-237B7F2191DC Q33350700-C5840AB9-00D1-4D97-BB4B-D630337D5E5A Q33361942-CD42B99A-01E1-4A7B-91B4-3439BCD3BE45 Q33412190-F8CB4614-F11C-4AC5-AA69-3E02880D2015 Q33419836-0F52B3E7-0B2D-4EB3-9445-E652475DA716 Q33679954-E5CFFD99-4A23-41CD-9FDA-959F4B2708F7 Q34046083-A0021908-33C4-42AA-9E39-7D8F97983159 Q34230088-553B8D90-8459-4CF3-9C83-A546C36E8F7A Q34235005-A7EEFB87-4CBA-44A6-BD77-2AE93AE918BB Q34737817-7AAE31D2-56BC-42A2-A400-CEF7F7A44E6E Q34746693-328AC192-0C76-4025-A4BC-D60649B44DCC Q35133990-AAE07786-F362-48B4-9089-FC53B8F2DB5C Q35210325-08D11654-1113-4846-831F-0CEC16017AFA

P2860

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

http://www.wikidata.org/entity/Q30357432

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Passive immunoprophylaxis and ...... nza A H5 hemagglutinin in mice

@ast

Passive immunoprophylaxis and ...... nza A H5 hemagglutinin in mice

@en

type

label

Passive immunoprophylaxis and ...... nza A H5 hemagglutinin in mice

@ast

Passive immunoprophylaxis and ...... nza A H5 hemagglutinin in mice

@en

prefLabel

Passive immunoprophylaxis and ...... nza A H5 hemagglutinin in mice

@ast

Passive immunoprophylaxis and ...... nza A H5 hemagglutinin in mice

@en

P1433

Q30357432-D00AEEA1-6C10-4D2A-BA62-1526AEB4048F

P1476

Q30357432-A4CC4BE7-0DF5-441B-ACBA-6743D4DFADC6

P2093

Q30357432-0C999B5C-A8CE-4E70-95D5-8CB1C17E9697

Q30357432-33801433-B82F-4E70-BF70-AD78A73289CC

Q30357432-745227F1-48C2-430E-857A-6AC97B5B102E

Q30357432-E04142A7-690F-412C-94E7-E20DF3CBA1DE

P2860

Q30357432-00F139F6-A7FE-47FF-B627-8B7519E0E893

Q30357432-0BC7D4AE-D1A5-4225-98E9-BB56082B3ECC

Q30357432-20AA52E7-CC30-4677-AEC5-3BD197BD2434

Q30357432-22C39808-8E61-4EEC-B17D-47D1E830BA76

Q30357432-230460B1-4DFD-47C8-8BDC-938F9CF649EF

Q30357432-2A6EE45F-1E31-4F36-BF25-D8DA6F80906A

Q30357432-2ED55DB7-92E8-4521-AE31-C91D6A287EF6

Q30357432-3978A44B-1916-4248-978C-75298FC05AD2

Q30357432-400E7559-AF5B-4B58-8896-E73D2BE1CF86

Q30357432-44A9C471-2473-467D-B6EB-EF9A1E3AE417

P2888

Q30357432-CF599F96-E777-49B1-A247-B0E14E0226B2

P304

Q30357432-E57A0C1B-83E8-47B6-B4AF-3467B1E6E632

P31

Q30357432-364F8D5B-3039-487C-AEEF-AA2B05F96758

P356

Q30357432-A5750CB8-F019-480F-A134-6A240931E62F

P478

Q30357432-AEB742B4-BF07-45A9-8B70-947A6F27762C

P50

Q30357432-0C170464-4A4E-4B87-851F-8E130563867D

Q30357432-980BBB72-B3C5-408C-B870-F287BE3C93DF

P577

Q30357432-1E25BE88-EC0D-43F9-ADC6-E5469AD0714F

P5875

Q30357432-05E3E288-2F0E-4504-84E7-E2BAB668A9E8

P6179

Q30357432-F77DF741-1603-4857-9EB6-AA1B4450DCAA

P698

Q30357432-48AE9A96-DDD3-4D09-AF3E-DF1A16E0EEBE

P921

Q30357432-2B52AA54-FF98-446C-8DE0-3BBE0E308C23

P932

Q30357432-FB9AE4AF-F29C-467E-AFA3-95E57F10C293

P356

1465-9921-7-126

P1433

Respiratory Research

P1476

Passive immunoprophylaxis and ...... nza A H5 hemagglutinin in mice

@en

P2093

Adrianus C M Boon

http://www.w3.org/2001/XMLSchema#string

Angeline P C Lim

http://www.w3.org/2001/XMLSchema#string

Ashley Webb

http://www.w3.org/2001/XMLSchema#string

Brendon J Hanson

http://www.w3.org/2001/XMLSchema#string

P2860

H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes

Antigen distortion allows influenza virus to escape neutralization

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression

Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control

Strategies for containing an emerging influenza pandemic in Southeast Asia

Oseltamivir resistance during treatment of influenza A (H5N1) infection

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Confronting the avian influenza threat: vaccine development for a potential pandemic.

P2888

1465-9921-7-126

P304

126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-7-126

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6754144

http://www.w3.org/2001/XMLSchema#string

P6179

1002980258

http://www.w3.org/2001/XMLSchema#string

P698

17040574

http://www.w3.org/2001/XMLSchema#string

P921

P932

1626464

http://www.w3.org/2001/XMLSchema#string